Characterization of the enzymatic specificity of the IGF-dependent insulin-like growth factor binding protein-4 (IGFBP-4) protease

Growth Hormone and IGF Research

Volumn 10, Issue 6, 2000, Pages 360-366

  Chelius, Dirk ^a   Conover, Cheryl A ^b   Baldwin, Michael A ^c   Spencer, E Martin ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

IGFBP 4; IGFBP 4 protease; Mass spectrometry; PAPP A

Indexed keywords

KALLIKREIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROTEINASE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 4;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ASSAY; ENZYME SPECIFICITY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0034491589     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.2000.0177     Document Type: Article

References (39)

1. Insulin-like growth factors and their binding proteins: Biological actions
2. Insulin-like growth factors and their binding proteins
3. Insulin-like growth factors and ovarian follicular development
4. Insulin-like growth factors and cancer
5. The insulin-like growth factors
6. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis
7. Insulin-like growth factors: A role in growth hormone negative feedback and body weight regulation via brain
8. Insulin like growth factor-binding protein proteolysis: An emerging paradigm in insulin-like growth factor physiology
9. Insulin-like growth factor binding proteins
10. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action
11. An inhibitory insulin-like growth factor binding protein (In-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived In-IGFBP
12. Characterization and partial purification of the insulin-like growth factor (IGF)-dependent IGF binding protein-4-specific protease from human fibroblast conditioned media
13. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: Implications in bone cell physiology
14. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases
15. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells
16. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: Evidence for ligand-induced proteolysis
17. Insulin-like growth factor-I (IGF-I) enhanced proteolysis of IGF-binding protein-4 in conditioned medium from primary cultures of human decidua: Independence from IGF receptor binding
18. Effect of follicle stimulating hormone and insulin-like growth factors on proteolysis of insulin-like growth factor binding protein-4 in human granulosa cells
19. Estrogen-but not androgen-dominant human ovarian follicular fluid contains an insulin-like growth factor binding protein-4 protease
20. Insulin-like growth factor binding protein proteolysis in bone cell models
21. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies
22. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A
23. Clinical applications of pregnancy protein estimations with particular reference to pregnancy-associated plasma protein A (PAPP-A)
24. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group
25. Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants
26. Identification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma
27. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies
28. Studies on human pregnancy-induced insulin-like growth factor (IGF)-binding protein-4 proteases in serum: Determination of IGF-II dependency and localization of cleavage site
29. Insulin-like growth factor-I (IGF-I) enhanced proteolysis of IGF-binding protein-4 in conditioned medium from primary cultures of human decidua: Independence from IGF receptor binding
30. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts
31. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases
32. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: Implications in bone cell physiology
33. Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells
34. Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4
35. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action
36. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism
37. Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: Control of IGF signalling to bone cells by IGFBP-3-specific proteolysis?